These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy. Srirajaskanthan R; Kayani I; Quigley AM; Soh J; Caplin ME; Bomanji J J Nucl Med; 2010 Jun; 51(6):875-82. PubMed ID: 20484441 [TBL] [Abstract][Full Text] [Related]
28. Cardiac neuroendocrine tumour metastases: case reports and review of the literature. Bonsen LR; Aalbersberg EA; Tesselaar M; Stokkel MP Nucl Med Commun; 2016 May; 37(5):461-5. PubMed ID: 26671851 [TBL] [Abstract][Full Text] [Related]
29. Brain Metastases of a Neuroendocrine Tumor Visualized by 68Ga-DOTATATE PET/CT. Hoberück S; Michler E; Zöphel K; Platzek I; Kotzerke J; Brogsitter C Clin Nucl Med; 2019 Jan; 44(1):50-52. PubMed ID: 30371585 [TBL] [Abstract][Full Text] [Related]
30. 68Ga-DOTATATE PET/CT compared to standard imaging in metastatic neuroendocrine tumors: a more sensitive test to detect liver metastasis? Jackson T; Darwish M; Cho E; Nagatomo K; Osman H; Jeyarajah DR Abdom Radiol (NY); 2021 Jul; 46(7):3179-3183. PubMed ID: 33665733 [TBL] [Abstract][Full Text] [Related]
31. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET. Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461 [TBL] [Abstract][Full Text] [Related]
32. The Detection of Cardiac Adrenocorticotropic Hormone-Secreting Neuroendocrine Tumor With the Help of 68Ga-DOTATATE PET/CT. Hou G; Jiang Y; Cheng X Clin Nucl Med; 2020 Feb; 45(2):136-138. PubMed ID: 31876827 [TBL] [Abstract][Full Text] [Related]
33. [Detection of neuroendocrine tumors by positron emission tomography-computed tomography with 68Ga-DOTATATE: report of one case]. Amaral H; Pruzzo R; Redondo F; Gil MC; Pizarro A; de la Fuente H; Butte JM; Coudeu TM Rev Med Chil; 2009 Apr; 137(4):537-41. PubMed ID: 19623420 [TBL] [Abstract][Full Text] [Related]
34. 68Ga-DOTATATE Uptake in Pancreatic Metastasis of Renal Cell Carcinoma Mimicking Pancreatic Neuroendocrine Tumor. Soydal C; Nak D; Araz M; Demirkazik A; Kucuk NO Clin Nucl Med; 2019 Oct; 44(10):795-796. PubMed ID: 31306201 [TBL] [Abstract][Full Text] [Related]
35. Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT. Lu Y Clin Nucl Med; 2019 Nov; 44(11):914-915. PubMed ID: 31306189 [TBL] [Abstract][Full Text] [Related]
36. 64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients. Pfeifer A; Knigge U; Binderup T; Mortensen J; Oturai P; Loft A; Berthelsen AK; Langer SW; Rasmussen P; Elema D; von Benzon E; Højgaard L; Kjaer A J Nucl Med; 2015 Jun; 56(6):847-54. PubMed ID: 25952736 [TBL] [Abstract][Full Text] [Related]
37. A Case Series of Molecular Imaging of Glucagonoma After Initial Therapy-68Ga-DOTATATE PET/CT Reveals Similar Results as in Neuroendocrine Tumors of Other Origin in Follow-up and Re-evaluation. Rottenburger C; Papantoniou D; Mandair D; Caplin M; Navalkissoor S Clin Nucl Med; 2018 Apr; 43(4):252-255. PubMed ID: 29432346 [TBL] [Abstract][Full Text] [Related]
39. 68Ga-FAPI PET/CT Versus 68Ga-DOTATATE PET/CT in the Evaluation of a Patient With Neuroendocrine Tumor. Kömek H; Gündoğan C; Can C Clin Nucl Med; 2021 May; 46(5):e290-e292. PubMed ID: 33351508 [TBL] [Abstract][Full Text] [Related]
40. Current Concepts in Bodei L; Ambrosini V; Herrmann K; Modlin I J Nucl Med; 2017 Nov; 58(11):1718-1726. PubMed ID: 28818983 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]